Kirby Institute, UNSW |Media release | Published on 04 Sep 2024 Over the last decade, HIV diagnoses in Australia have continued to follow a downward trend, according to new data released today by the Kirby Institute at UNSW Sydney. While there were 722 new HIV diagnoses reported nationally in 2023 – up from 553 in 2022 – the researchers still reported a lower number of annual cases compared to...
ViiV Healthcare, July 2023 Join in the discussion with Dr Nneka Nwokolo on health issues faced by women living with HIV. Dr Nwokolo is Head of Global Patient Affairs at ViiV Healthcare and an honorary Consultant Physician in Sexual Health and HIV Medicine at Chelsea and Westminster Hospital in London where she continues to see patients in a combined general and menopause clinic. Date & time:...
van Santen DK, Sacks-Davis R, Stewart A, Boyd A, Young J, van der Valk M, Smit C, Rauch A, Braun DL, Jarrin I, Berenguer J, Lazarus JV, Lacombe K, Requena MB, Wittkop L, Leleux O, Salmon D, Bonnet F, Matthews G, Doyle JS, Spelman T, Klein MB, Prins M, Asselin J, Stoové MA, Hellard M; InCHEHC study group. Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus...
UNSW, June 2022 The report on the 2022 Adelaide Gay Community Periodic Survey has been published. The Gay Community Periodic Surveys (GCPS) are repeated, cross-sectional surveys of gay men conducted in the metropolitan areas of seven Australian states and territories. They are a key part of Australia’s behavioural surveillance system for HIV, monitoring sexual practices, drug use and patterns of...
Kirby Institute, UNSW, 17th April 2023 A ten-year study into the impact of HIV ‘treatment as prevention’ has found that a 27 per cent increase in people accessing effective HIV treatment saw HIV infections decrease by 66 per cent between 2010 to 2019, in NSW and Victoria. The findings, published today in Lancet HIV, show the success of HIV treatment as prevention in reducing new HIV infections...
NAPWHA, ASHM, AFAO, May 2022 From 1st July, people with HIV who are ineligible for Medicare, and who previously received HIV medication through compassionate access schemes, will be required to transition to alternative access arrangements in order to receive government-funded treatment*. Option 1: individuals will need to engage in care with a public hospital-based physician and have their...